Login
$AMIX
$2.07 -$0.03 (1.43%) Close

$AMIX 4 SEC Filings

Filed On Filing
21 Sep 2026 Form 4: Smith Trent N., CFO

Received 15,000 shares as a grant or award

08 Sep 2026 Form 4: Klemp Walter V, Director

Received 13,000 shares as a grant or award

08 Sep 2026 Form 4: Bisson Lori, Director

Received 13,000 shares as a grant or award

08 Sep 2026 Form 4: Hauser Bradley, CEO and President

Received 27,000 shares as a grant or award

13 Aug 2025 Form 4: Klemp Walter V, Director

Disposed of 8,773 Option (Right to buy) (Disposition to Issuer)

13 Aug 2025 Form 4: Hauser Bradley, CEO and President

Disposed of 45,000 Option (Right to buy) (Disposition to Issuer)

13 Aug 2025 Form 4: Capelli Christopher, Director

Disposed of 3,750 Option (Right to buy) (Disposition to Issuer)

13 Aug 2025 Form 4: Bisson Lori, Director

Disposed of 65,542 Option (Right to buy) (Disposition to Issuer)

13 Aug 2025 Form 4: Smith Trent N., CFO

Disposed of 32,655 Option (Right to buy) (Disposition to Issuer)

26 Jul 2024 Form 4: Robins David Andrew, Director

Acquired 103,990 Warrant (Right to buy) (Open Market Purchase) ($104)

24 Jun 2024 Form 4: Smith Trent N., CFO

Granted 228,087 Option (Right to buy)

24 Jun 2024 Form 4: Klemp Walter V, Director

Granted 175,452 Option (Right to buy)

24 Jun 2024 Form 4: Bisson Lori, Director

Granted 377,221 Option (Right to buy)

20 Jun 2024 Form 4: Hauser Bradley, CEO and President

Granted 900,000 Option (Right to buy)

20 Jun 2024 Form 4: BioStar Ventures III, L.p., 10% owner

Acquired 1,088,000 Warrant to Purchase Common Stock (Open Market Purchase) ($30.5K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support